Clinical Trials Directory

Trials / Completed

CompletedNCT04784260

Microbiome Influence on Seminal Quality

Microbiome Influence on Seminal Quality on Semen Donors

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Instituto Valenciano de Infertilidad, IVI Alicante · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The microbiome plays an important role in health and in some unknown etiologies. Some previous studies have identified bacteria in semen as a potential factor in male infertility. More studies are needed to discover associations between microbiomes and semen quality. In this study, forty semen samples from donors candidates will be collected where clinical criteria for seminal quality (volume, concentration, motility and morphology) will be measured and bacterial communities examined. With the next-generation sequencing of gene technology and bioinformatic analysis, we can investigate the associations between bacterial communities and seminal quality. It would be interesting to know if the proportion of certain bacteria is significantly higher in samples of normal seminal quality or significantly higher in samples of low seminal quality. This study could contribute to the current understanding of certain etiologies of male fertility.

Detailed description

Surplus semen samples will be collected from donor candidates who come to the IVI Alicante clinic with ages between 18 and 35 years old and who intend to participate in the donation program for the semen bank, and come to evaluate their quality. Informed consent for this study will be given to all of them, which they will have to return signed. Depending on the semen quality evaluated in the diagnostic sample within the usual practice, in the laboratory the participants will be divided into 2 groups according to the WHO reference values in terms of sperm concentration and percentage of progressive motility: * Group A (Normozoospermics): ≥15 mill / ml and\> 32% progressive mobility. * Group B (Non-normozoospermic): \<15 mill / ml and \<32% progressive mobility. The study will consist of 2 years. The first year will be used to collect all the diagnostic seminal samples from donor candidates, and the second year will be used in its first months to analyze the microbiome by extracting DNA from ejaculates, amplifying bacterial DNA with targeted primers. to the bacterial 16S rRNA gene regions, sequencing, library preparation and bioinformatic analysis.

Conditions

Interventions

TypeNameDescription
OTHERMicrobiome analysisEvaluate the bacterial composition in sperm from the different groups

Timeline

Start date
2020-06-01
Primary completion
2023-01-12
Completion
2023-03-10
First posted
2021-03-05
Last updated
2023-03-13

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04784260. Inclusion in this directory is not an endorsement.